0001103021-22-000053.txt : 20220311 0001103021-22-000053.hdr.sgml : 20220311 20220311080852 ACCESSION NUMBER: 0001103021-22-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220309 FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Jeffrey Allen CENTRAL INDEX KEY: 0001500210 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 22731201 MAIL ADDRESS: STREET 1: BIODELIVERY SCIENCES INTERNATIONAL, INC. STREET 2: 4131 PARKLAKE AVE., SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_164700411850804.xml FORM 4 X0306 4 2022-03-09 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001500210 Bailey Jeffrey Allen 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 1 1 0 0 Chief Executive Officer Common Stock 2022-03-09 4 M 0 5333 0 A 105133 D Restricted Stock Units 0.0 2022-03-09 4 M 0 5333 0 D 2023-03-08 Common Stock 5333.0 5334 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of 5,333 of RSUs granted to the Reporting Person on March 9, 2020 under the Issuer's 2019 Stock Option Incentive Plan. The remainder of the RSUs under this grant will vest on March 9, 2023. Jeffrey A Bailey 2022-03-11